Correlation of Hepatitis C, Alcoholic Liver Disease, and Renal Failure With Hyperfibrinolysis in Liver Failure

NCT02737345 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2017-11-08

No results posted yet for this study

Summary

1. Further characterize the incidence of hyperfibrinolysis in cirrhotics
2. Correlate hyperfibrinolysis with

1. hepatitis C
2. alcoholic liver disease
3. the subset of a\&b with renal failure with and without dialysis
3. Better describe the hyperfibrinolytic ROTEM profile in cirrhotics

Conditions

  • Cirrhosis

Interventions

OTHER

Rotem

Sponsors & Collaborators

  • Scott Allen

    lead OTHER

Principal Investigators

  • Scott Allen, MD · University of Utah

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-01
Primary Completion
2017-04-01
Completion
2017-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02737345 on ClinicalTrials.gov